Syquant Capital SAS’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Syquant Capital SAS’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,462	Closed	-$12.5M	–	66
2021 Q1	$12.5M	Buy	+57,462	New	+$10.8M	3.23%	11

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Syquant Capital SAS's GWPH Position: Q2 2021 in Review

Syquant Capital SAS sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 57,462 shares — an estimated $12.5M sold.

Syquant Capital SAS first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $12.5M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Syquant Capital SAS reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Syquant Capital SAS sold 57,462 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $12.5M.
Syquant Capital SAS first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Syquant Capital SAS's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.5M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Syquant Capital SAS's 13F filing for Q2 2021, filed 14 Jul 2021.